Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jul. 31, 2018	Aug. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	STREAMLINE HEALTH SOLUTIONS INC.
Entity Central Index Key	0001008586
Document Type	10-Q
Document Period End Date	Jul. 31, 2018
Amendment Flag	false
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--01-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		20,039,893

Condensed Consolidated Balance Sheets - USD ($)	Jul. 31, 2018	Jan. 31, 2018
Current assets:
Cash and cash equivalents	$ 3,246,395	$ 4,619,834
Accounts receivable, net of allowance for doubtful accounts of $267,221 and $349,058, respectively	2,238,088	3,001,170
Contract receivables	826,277	223,791
Prepaid hardware and third-party software for future delivery	0	5,858
Prepaid client maintenance contracts	560,004	506,911
Other prepaid assets	828,257	742,232
Other current assets	367,326	546,885
Total current assets	8,066,347	9,646,681
Property and equipment:
Computer equipment	2,876,707	2,852,776
Computer software	704,562	730,950
Office furniture, fixtures and equipment	662,157	683,443
Leasehold improvements	582,271	729,348
Property and equipment, gross	4,825,697	4,996,517
Accumulated depreciation and amortization	(3,956,221)	(3,834,153)
Property and equipment, net	869,476	1,162,364
Contract receivables, less current portion	683,031	0
Capitalized software development costs, net of accumulated amortization of $19,304,635 and $18,658,183, respectively	5,190,076	4,307,351
Intangible assets, net of accumulated amortization of $7,438,679 and $6,968,786, respectively	5,365,257	5,835,151
Goodwill	15,537,281	15,537,281
Other	378,672	642,226
Total non-current assets	28,023,793	27,484,373
Total assets	36,090,140	37,131,054
Current liabilities:
Accounts payable	789,239	421,425
Accrued compensation	883,386	342,351
Accrued other expenses	1,402,972	609,582
Current portion of term loan	596,984	596,984
Deferred revenues	8,273,251	9,481,807
Other	37,135
Total current liabilities	11,982,967	11,452,149
Non-current liabilities:
Term loan, net of current portion and deferred financing cost of $92,808 and $128,275, respectively	3,638,328	3,901,353
Royalty liability	874,437	2,469,193
Deferred revenues, less current portion	882,672	332,645
Other	316,514	274,128
Total non-current liabilities	5,711,951	6,977,319
Total liabilities	17,694,918	18,429,468
Series A 0% Convertible Redeemable Preferred Stock, $.01 par value per share, $8,686,392 and $8,849,985 redemption value, 4,000,000 shares authorized, 2,895,464 and 2,949,995 shares issued and outstanding, respectively	8,686,392	8,849,985
Stockholders' equity:
Common stock, $.01 par value per share, 45,000,000 shares authorized; 20,039,893 and 20,005,977 shares issued and outstanding, respectively	200,399	200,060
Additional paid in capital	82,284,455	81,776,606
Accumulated deficit	(72,776,024)	(72,125,065)
Total stockholders' equity	9,708,830	9,851,601
Total liability and stockholders' equity	$ 36,090,140	$ 37,131,054

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	6 Months Ended	12 Months Ended
	Jul. 31, 2018	Jan. 31, 2018
Allowance for doubtful accounts	$ 267,221	$ 349,058
Accumulated amortization of capitalized software development costs	19,304,635	18,658,183
Accumulated amortization of intangible assets	7,438,679	6,968,786
Deferred financing costs, accumulated amortization	$ 92,808	$ 128,275
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Number of authorized shares of common stock (in shares)	45,000,000	45,000,000
Common stock, shares issued (in shares)	20,039,893	20,005,977
Common stock, shares outstanding (in shares)	20,039,893	20,005,977
Series A Preferred Stock
Preferred stock dividend rate	0.00%	0.00%
Convertible redeemable preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Convertible redeemable preferred stock, redemption value	$ 8,686,392	$ 8,849,985
Convertible redeemable preferred stock, shares authorized (in shares)	4,000,000	4,000,000
Convertible redeemable preferred stock, shares issued (in shares)	2,895,464	2,949,995
Convertible redeemable preferred stock, shares outstanding (in shares)	2,895,464	2,949,995

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
Revenues:
Systems sales	$ 385,875	$ 328,692	$ 1,517,549	$ 707,415
Professional services	271,121	571,812	509,435	991,847
Audit services	247,843	294,441	607,556	639,460
Maintenance and support	3,216,251	3,278,562	6,525,355	6,633,334
Software as a service	1,147,642	1,442,652	2,372,010	2,867,784
Total revenues	5,268,732	5,916,159	11,531,905	11,839,840
Operating expenses:
Cost of systems sales	289,890	596,799	539,874	1,162,850
Cost of professional services	697,467	543,206	1,403,697	1,258,421
Cost of audit services	300,081	391,439	694,060	832,078
Cost of maintenance and support	566,248	768,140	1,214,587	1,574,662
Cost of software as a service	281,872	285,832	598,259	625,208
Selling, general and administrative	2,518,893	2,790,171	5,767,950	6,163,699
Research and development	1,212,845	1,495,972	2,275,164	3,052,910
Loss on exit of operating lease	806,163		806,163
Total operating expenses	6,673,459	6,871,559	13,299,754	14,669,828
Operating loss	(1,404,727)	(955,400)	(1,767,849)	(2,829,988)
Other expense:
Interest expense	(110,385)	(120,377)	(226,603)	(247,645)
Miscellaneous expense	(5,383)	(19,681)	(93,028)	(57,725)
Loss before income taxes	(1,520,495)	(1,095,458)	(2,087,480)	(3,135,358)
Income tax expense	(1,713)	(2,607)	(3,427)	(5,215)
Net loss	$ (1,522,208)	$ (1,098,065)	$ (2,090,907)	$ (3,140,573)
Net loss per common share - basic and diluted (in dollars per share)	$ (0.08)	$ (0.06)	$ (0.10)	$ (0.16)
Weighted average number of common shares - basic and diluted (in shares)	19,971,090	19,834,859	19,978,757	19,765,125

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Operating activities:
Net loss	$ (2,090,907)	$ (3,140,573)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	324,640	403,090
Amortization of capitalized software development costs	646,452	1,143,624
Amortization of intangible assets	469,894	666,114
Amortization of other deferred costs	228,497	161,064
Valuation adjustment for warrants liability	0	(45,831)
Other valuation adjustments	56,211	86,192
Gain on disposal of fixed assets	(1,555)	(720)
Loss on exit of operating lease	806,163
Share-based compensation expense	366,906	555,229
Provision for accounts receivable	(64,154)	166,170
Changes in assets and liabilities:
Accounts and contract receivables	292,442	99,086
Other assets	105,148	(333,401)
Accounts payable	367,814	449,929
Accrued expenses	587,226	(352,132)
Deferred revenues	(1,618,004)	(822,867)
Net cash provided by (used in) operating activities	476,773	(965,026)
Investing activities:
Purchases of property and equipment	(14,457)	(9,812)
Proceeds from sales of property and equipment	14,225
Capitalization of software development costs	(1,529,177)	(844,448)
Net cash used in investing activities	(1,529,409)	(854,260)
Financing activities:
Principal repayments on term loan	(298,492)	(813,197)
Principal payments on capital lease obligation	0	(68,149)
Payments related to settlement of employee shared-based awards	(57,699)	(37,002)
Proceeds from exercise of stock options and stock purchase plan	35,388
Net cash used in financing activities	(320,803)	(918,348)
Net decrease in cash and cash equivalents	(1,373,439)	(2,737,634)
Cash and cash equivalents at beginning of period	4,619,834	5,654,093
Cash and cash equivalents at end of period	$ 3,246,395	$ 2,916,459

Basis of Presentation	6 Months Ended
Basis of Presentation	Jul. 31, 2018
Basis of Presentation
BASIS OF PRESENTATION	NOTE 1 — BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements have been prepared by Streamline Health Solutions, Inc. (“we”, “us”, “our”, “Streamline”, or the “Company”), pursuant to the rules and regulations applicable to quarterly reports on Form 10‑Q of the U.S. Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading. In the opinion of our management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent annual report on Form 10‑K, Commission File Number 0‑28132. Operating results for the six months ended July 31, 2018 are not necessarily indicative of the results that may be expected for the fiscal year ending January 31, 2019.

Summary of Significant Accounting Policies

6 Months Ended

Jul. 31, 2018

Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our significant accounting policies are presented in “Note 2 – Significant Accounting Policies” in the fiscal year 2017 Annual Report on Form 10‑K. Users of financial information for interim periods are encouraged to refer to the footnotes to the consolidated financial statements contained in the Annual Report on Form 10‑K when reviewing interim financial results.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Fair Value of Financial Instruments

The Financial Accounting Standards Board’s (“FASB”) authoritative guidance on fair value measurements establishes a framework for measuring fair value, and expands disclosure about fair value measurements. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair values. Under this guidance, assets and liabilities carried at fair value must be classified and disclosed in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value based on the short-term maturity of these instruments. Cash and cash equivalents are classified as Level 1. The carrying amount of our long-term debt approximates fair value since the variable interest rates being paid on the amounts approximate the market interest rate. Long-term debt is classified as Level 2.

The table below provides information on our liabilities that are measured at fair value on a recurring basis:


			Quoted Prices in		Significant Other		Significant
	Total Fair		Active Markets		Observable Inputs		Unobservable Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
At July 31, 2018
Royalty liability (1) (3)	$	874,000	$	—	$	—	$	874,000

At January 31, 2018
Royalty liability (1) (2)	$	2,469,000	$	—	$	—	$	2,469,000

(1)

The initial fair value of royalty liability was determined by management with the assistance of an independent third-party valuation specialist, and by management thereafter. Fair value adjustments are included within miscellaneous expense in the condensed consolidated statements of operations.

(2)

The fair value of the royalty liability was determined based on the probability-weighted revenue scenarios for the Streamline Health® Clinical AnalyticsTM solution (“Clinical Analytics”) licensed from Montefiore Medical Center (discussed in Note 3 - Acquisitions and Divestitures).

(3)

Following the modification of the Royalty Agreement in the second quarter of fiscal 2018 (discussed in Note 3 - Acquisitions and Divestitures), the royalty liability was significantly reduced as a result of the commitment to fulfill a portion of our obligation by providing incremental maintenance services. The fair value of the royalty liability was determined based on the portion of the modified royalty commitment payable in cash.

Revenue Recognition

We derive revenue from the sale of internally-developed software, either by licensing for local installation or by a software as a service (“SaaS”) delivery model, through our direct sales force or through third-party resellers. Licensed, locally-installed clients on a perpetual model utilize our support and maintenance services for a separate fee, whereas term-based locally installed license fees and SaaS fees include support and maintenance. We also derive revenue from professional services that support the implementation, configuration, training and optimization of the applications, as well as audit services provided to help clients review their internal coding audit processes. Additional revenues are also derived from reselling third-party software and hardware components.

We recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”), the new revenue recognition standards established by ASU 2014‑09. The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

We commence revenue recognition (Step 5 below) in accordance with that core principle after applying the following steps:

Step 1: Identify the contract(s) with a customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

We follow the accounting revenue guidance under ASC 606 to determine whether contracts contain more than one performance obligation. Performance obligations are the unit of accounting for revenue recognition and generally represent the distinct goods or services that are promised to the customer. Revenue is recognized net of any taxes collected from customers and subsequently remitted to governmental authorities.

If we determine that we have not satisfied a performance obligation, we will defer recognition of the revenue until the performance obligation is deemed to be satisfied. Maintenance and support and SaaS agreements are generally non-cancelable or contain significant penalties for early cancellation, although clients typically have the right to terminate their contracts for cause if we fail to perform material obligations. However, if non-standard acceptance periods, non-standard performance criteria, or cancellation or right of refund terms are required, revenue is recognized upon the satisfaction of such criteria.

Significant judgment is required to determine the standalone selling price (“SSP”) for each performance obligation, the amount allocated to each performance obligation and whether it depicts the amount that the Company expects to receive in exchange for the related product and/or service. As the selling prices of the Company’s software licenses are highly variable, the Company estimates SSP of its software licenses using the residual approach when the software license is sold with other services and observable SSPs exist for the other services. The Company estimates the SSP for maintenance, professional services, and audit services based on observable standalone sales.

Contract Combination

The Company may execute more than one contract or agreement with a single customer. The Company evaluates whether the agreements were negotiated as a package with a single objective, whether the amount of consideration to be paid in one agreement depends on the price and/or performance of another agreement, or whether the good or services promised in the agreements represent a single performance obligation. The conclusions reached can impact the allocation of the transaction price to each performance obligation and the timing of revenue recognition related to those arrangements.

The Company has utilized the portfolio approach as the practical expedient. We have applied the revenue model to a portfolio of contracts with similar characteristics where we expected that the financial statements would not differ materially from applying it to the individual contracts within that portfolio.

Systems Sales

The Company’s software license arrangements provide the customer with the right to use functional intellectual property. Implementation, support, and other services are typically considered distinct performance obligations when sold with a software license unless these services are determined to significantly modify the software. Revenue is recognized at a point in time. Typically, this is upon shipment of components or electronic download of software.

Maintenance and Support Services

Our maintenance and support obligations include multiple discrete performance obligations, with the two largest being unspecified product upgrades or enhancements, and technical support, which can be offered at various points during a contract period. We believe that the multiple discrete performance obligations within our overall maintenance and support obligations can be viewed as a single performance obligation since both the unspecified upgrades and technical support are activities to fulfill the maintenance performance obligation and are rendered concurrently. Annual maintenance and support agreements entitle clients to technology support, version upgrades, bug fixes and service packs. We recognize maintenance and support revenue over time.

Software-Based Solution Professional Services

The Company provides various professional services to customers with software licenses. These include project management, software implementation and software modification services. Revenues from arrangements to provide professional services are generally distinct from the other promises in the contract and are recognized as the related services are performed. Consideration payable under these arrangements is either fixed fee or on a time-and-materials basis.

Software as a Service

SaaS-based contracts include use of the Company’s platform, implementation, support and other services which represent a single promise to provide continuous access to its software solutions. The Company recognizes revenue over time for the life of the contract.

We defer the direct costs, which includes salaries and benefits, for professional services related to SaaS contracts. These deferred costs will be amortized over the identical term as the associated revenues. As of July 31, 2018, and January 31, 2018, we had deferred costs of $335,000 and $471,000, respectively, net of accumulated amortization of $443,000 and $312,000, respectively. Amortization expense of these costs was $91,000 and $43,000 for the three months ended July 31, 2018 and 2017, respectively, and $193,000 and $126,000 for the six months ended July 31, 2018 and 2017, respectively.

Audit Services

Audit services are a separate performance obligation. We recognize revenue over time as the services are performed.

Comparative GAAP Financials

The adoption of the new standard has the following impact to the Company’s condensed consolidated statements of operations for the six months ended July 31, 2018:


	Six Months Ended July 31, 2018
	As reported under ASC 606		Balances without adoption of ASC 606		Adjustments due to ASC 606
Revenues
Systems sales	$	1,518,000	$	2,008,000	$	(490,000)
Maintenance and support		6,525,000		6,529,000		(4,000)


	As of July 31, 2018
	As reported under ASC 606		Balances without adoption of Topic 606		Adjustments due to ASC 606
Assets
Contract receivables, current	$	826,000	$	474,000	$	352,000
Contract receivables, noncurrent		683,000		190,000		493,000

Liabilities
Deferred revenues, current		8,273,000		8,414,000		(141,000)

Shareholders' Equity
Accumulated deficit	$	(72,776,000)	$	(73,762,000)	$	986,000

Disaggregation of Revenue

The following table provides information about disaggregated revenue by type and nature of revenue stream:


	Six Months Ended July 31, 2018
	Recurring Revenue		Non-recurring Revenue		Total
Systems sales	$	166,000	$	1,352,000	$	1,518,000
Professional services		—		509,000		509,000
Audit services		—		608,000		608,000
Maintenance and support		6,525,000		—		6,525,000
Software as a service		2,372,000		—		2,372,000
Total revenue:	$	9,063,000	$	2,469,000	$	11,532,000

Contract Receivables and Deferred Revenues

The Company receives payments from customers based upon contractual billing schedules. Contract receivables include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Deferred revenues include payments received in advance of performance under the contract. Our contract receivables and deferred revenue are reported on an individual contract basis at the end of each reporting period. Contract receivables are classified as current or noncurrent based on the timing of when we expect to bill the customer. Deferred revenue is classified as current or noncurrent based on the timing of when we expect to recognize revenue. In the six-month period ended July 31, 2018, we recognized $6,791,000 in revenue from deferred revenues outstanding as of January 31, 2018.

The cumulative effect of changes related to the adoption of ASC 606 are reflected in the opening balance of accumulated deficit as shown below:


	As Reported January 31, 2018		Adjustments due to ASC 606		As Adjusted February 1, 2018
ASSETS
Contract receivables, current	$	224,000	$	283,000	$	507,000
Contract receivables, noncurrent		—		468,000		468,000

LIABILITIES
Deferred revenues, current		9,482,000		(689,000)		8,793,000

STOCKHOLDERS' EQUITY
Accumulated deficit	$	(72,125,000)	$	1,440,000	$	(70,685,000)

Transaction price allocated to the remaining performance obligations

Revenue allocated to remaining performance obligations represents contracted revenue that will be recognized in future periods, which is comprised of deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. Revenue allocated to remaining performance obligations was $23 million as of July 31, 2018, of which the Company expects to recognize approximately 62% over the next 12 months and the remainder thereafter.

Deferred commissions costs (contract acquisition costs)

Contract acquisition costs, which consists of sales commissions paid or payable, is considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions for initial and renewal contracts are deferred and then amortized on a straight-line basis over a period of benefit, which the Company has determined to be the customer life. As a practical expedient, we expense sales commissions as incurred when the amortization period of related deferred commission costs would have been one year or less.

Deferred commissions costs paid and payable are included on the condensed consolidated balance sheets within other prepaid assets and other current assets, respectively. Amortization expense associated with sales commissions is included in selling, general and administrative expenses on the condensed consolidated statements of operations.

Severance

From time to time, we enter into termination agreements with associates that may include supplemental cash payments, as well as contributions to health and other benefits for a specific time period subsequent to termination. For the three months ended July 31, 2018 and 2017, we incurred $4,000 and $3,000 in severance expenses, respectively, and $17,000 and $58,000 for the six months ended July 31, 2018 and 2017, respectively. At July 31, 2018 and January 31, 2018, we had accrued severance expenses of $6,000 and zero, respectively.

Equity Awards

We account for share-based payments based on the grant-date fair value of the awards with compensation cost recognized as expense over the requisite vesting period. We incurred total compensation expense related to stock-based awards of $144,000 and $288,000 for the three months ended July 31, 2018 and 2017, respectively, and $367,000 and $555,000 for the six months ended July 31, 2018 and 2017, respectively .

The fair value of the stock options granted is estimated at the date of grant using a Black-Scholes option pricing model. The option pricing model inputs (such as expected term, expected volatility, and risk-free interest rate) impact the fair value estimate. Further, the forfeiture rate impacts the amount of aggregate compensation. These assumptions are subjective and are generally derived from external (such as risk-free rate of interest) and historical (such as volatility factor, expected term, and forfeiture rates) data. Future grants of equity awards accounted for as stock-based compensation could have a material impact on reported expenses depending upon the number, value, and vesting period of future awards.

We issue restricted stock awards in the form of our common stock. The fair value of these awards is based on the market closing price per share on the date of grant. We expense the compensation cost of these awards as the restriction period lapses, which is typically a one- to four-year service period to the Company. In the six months ended July 31, 2018, 33,392 shares of common stock were surrendered to the Company to satisfy tax withholding obligations totaling $58,000 in connection with the vesting of restricted stock awards. Shares surrendered by the restricted stock award recipients in accordance with the applicable plan are deemed canceled, and therefore are not available to be reissued.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and for tax credit and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing net deferred tax assets, we consider whether it is more likely than not that some or all of the deferred tax assets will not be realized. We establish a valuation allowance when it is more likely than not that all or a portion of deferred tax assets will not be realized.

We provide for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether certain tax positions are more likely than not to be sustained upon examination by tax authorities. We believe we have appropriately accounted for any uncertain tax positions. The Company has recorded $314,000 and $286,000 in reserves for uncertain tax positions and corresponding interest and penalties as of July 31, 2018 and January 31, 2018, respectively.

Net Earnings (Loss) Per Common Share

We present basic and diluted earnings per share (“EPS”) data for our common stock. Basic EPS is calculated by dividing the net earnings (loss) attributable to common stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is calculated based on the profit or loss attributable to common stockholders and the weighted average number of shares of common stock outstanding, adjusted for the effects of all potential dilutive common stock issuances related to options, unvested restricted stock, warrants and convertible preferred stock. Potential common stock dilution related to outstanding stock options, unvested restricted stock and warrants is determined using the treasury stock method, while potential common stock dilution related to Series A Convertible Preferred Stock is determined using the “if converted” method.

Our unvested restricted stock awards and Series A Convertible Preferred Stock are considered participating securities under ASC 260, Earnings Per Share, which means the security may participate in undistributed earnings with common stock. Our unvested restricted stock awards are considered participating securities because they entitle holders to non-forfeitable rights to dividends or dividend equivalents during the vesting term. The holders of the Series A Convertible Preferred Stock would be entitled to share in dividends, on an as-converted basis, if the holders of common stock were to receive dividends, other than dividends in the form of common stock. In accordance with ASC 260, a company is required to use the two-class method when computing EPS when a company has a security that qualifies as a “participating security.” The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net earnings to allocate to common stockholders, earnings are allocated to both common and participating securities based on their respective weighted-average shares outstanding for the period. Diluted EPS for our common stock is computed using the more dilutive of the two-class method or the if-converted method.

In accordance with ASC 260, securities are deemed not to be participating in losses if there is no obligation to fund such losses. As of July 31, 2018, there were 2,895,464 shares of preferred stock outstanding, each of which is convertible into one share of our common stock. For the three and six months ended July 31, 2018 and 2017, the Series A Convertible Preferred Stock would have an anti-dilutive effect if included in diluted EPS and therefore, was not included in the calculation. For the three and six months ended July 31, 2018 and 2017, 649,087 and 831,587, respectively, unvested restricted shares of common stock were excluded from the diluted EPS calculation as their effect would have been anti-dilutive.

The following is the calculation of the basic and diluted net loss per share of common stock:


	Three Months Ended
	July 31, 2018		July 31, 2017
Net loss	$	(1,522,208)	$	(1,098,065)
Weighted average shares outstanding - Basic		19,971,090		19,834,859
Stock options, restricted stock, Series A Convertible Preferred Stock and warrants		—		—
Weighted average shares outstanding - Diluted		19,971,090		19,834,859
Basic net loss per share of common stock	$	(0.08)	$	(0.06)
Diluted net loss per share of common stock	$	(0.08)	$	(0.06)


	Six Months Ended
	July 31, 2018		July 31, 2017
Net loss	$	(2,090,907)	$	(3,140,573)
Weighted average shares outstanding - Basic		19,978,757		19,765,125
Stock options, restricted stock, Series A Convertible Preferred Stock and warrants		—		—
Weighted average shares outstanding - Diluted		19,978,757		19,765,125
Basic net loss per share of common stock	$	(0.10)	$	(0.16)
Diluted net loss per share of common stock	$	(0.10)	$	(0.16)

Diluted net loss per share excludes the effect of outstanding stock options that relate to 1,763,795 and 2,239,047 shares of common stock for the three and six months ended July 31, 2018 and 2017, respectively. The inclusion of these stock options would have been anti-dilutive. For the three and six months ended July 31, 2017, the warrants to purchase 1,400,000 shares of common stock would have an anti-dilutive effect if included in diluted net loss per share, and therefore were not included in the calculation. The warrants expired on February 16, 2018.

Recent Accounting Pronouncements

In May 2014, the FASB issued ASU 2014‑09, Revenue from Contracts with Customers,Topic 606 (“ASC 606”), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014‑09 defines a five-step process to achieve this principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2016, the FASB delayed the effective date by one year and the guidance became effective for us on February 1, 2018. The new revenue recognition guidance permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application as an adjustment to retained earnings (modified retrospective method). We have decided to adopt the standard effective February 1, 2018 using the modified retrospective method.

We have completed our assessment of our systems, available data and processes that will be affected by the implementation of this new revenue recognition guidance. The Company’s formal accounting policies have been established. As a result of the implementation of this standard, the Company recorded an adjustment to increase retained earnings as of February 1, 2018 by $1.4 million, related primarily to the timing of revenue. The most significant impact relates to our accounting for term software license revenue. We expect revenue related to SaaS-based offerings, hardware sales, maintenance and support, and audit services to remain substantially unchanged. For arrangements which include both software license and maintenance and support components, we expect to recognize the revenue attributed to license upfront at a point in time rather than over the term of the contract. We also expect to recognize license revenues upfront rather than be restricted to payment amounts due under extended payment term contracts as required under the previous guidance. Additionally, the new revenue recognition guidance requires the capitalization of all incremental costs of obtaining a contract with a customer that an entity expects to recover. We have already been capitalizing sales commissions associated with new and renewal contracts. We did not identify any other costs that would be eligible for capitalization under the new guidance. As a result, we did not record any additional deferral for such costs upon adoption of the new guidance on February 1, 2018.

In February 2016, the FASB issued ASU 2016‑02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The ASU is effective for annual periods beginning after December 15, 2018, including interim periods within those fiscal years. The update will be effective for us on February 1, 2019. Early adoption of the update is permitted. We are currently evaluating the impact of the adoption of this update on our consolidated financial statements and related disclosures.

In August 2016, the FASB issued ASU 2016‑15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, to clarify how certain cash receipts and cash payments should be presented and classified in the statement of cash flows. The ASU should be applied using a retrospective transition method to each period presented. The standard became effective for us on February 1, 2018. Early adoption of this update is permitted. The adoption of this ASU did not have a significant impact on our consolidated financial statements.

In January 2017, the FASB issued ASU 2017‑01, Business Combinations (Topic 805): Clarifying the Definition of a Business, to clarify the definition of a business to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The standard became effective for us on February 1, 2018. For the periods included in this report, there was no impact on our financial position or results of operations as a result of the adoption of this update.

In January 2017, the FASB issued ASU 2017‑04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, which removes Step 2 from the goodwill impairment test. The standard will be effective for us on February 1, 2020. Early adoption of this update is permitted. We do not expect that the adoption of this ASU will have a significant impact on our consolidated financial statements.

In May 2017, the FASB issued ASU 2017‑09, Compensation - Stock Compensation (Topic 718), Scope of Modification Accounting, to clarify which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The update became effective for us on February 1, 2018. For the periods included in this report, there was no impact on our financial position or results of operations as a result of the adoption of this update.

Acquisitions and Divestitures	6 Months Ended
Acquisitions and Divestitures	Jul. 31, 2018
Acquisitions and Divestitures
ACQUISITIONS AND DIVESTITURES	NOTE 3 — ACQUISITIONS AND DIVESTITURES Acquisition of a Montefiore Medical Center Solution On October 25, 2013, we entered into a Software License and Royalty Agreement (the “Royalty Agreement”) with Montefiore Medical Center (“Montefiore”) pursuant to which Montefiore granted us an exclusive, worldwide 15‑year license of Montefiore’s proprietary clinical analytics platform solution, Clinical Looking Glass® (“CLG”), now known as our Clinical Analytics solution. In addition, Montefiore assigned to us the existing license agreement with a customer using CLG. As consideration under the Royalty Agreement, we paid Montefiore a one-time initial base royalty fee of $3,000,000. Additionally, we originally committed that Montefiore would receive at least an additional $3,000,000 of on-going royalty payments related to future sublicensing of CLG by us within the first six and one-half years of the license term. On July 1, 2018, we entered into a joint amendment to the Royalty Agreement and the existing Software License and Support Agreement with Montefiore to modify the payment obligations of the parties under both agreements. According to the modified provisions, our obligation to pay on-going royalties under the Royalty Agreement was replaced with the obligation to (i) provide maintenance services for 24 months and waive associated maintenance fees, and (ii) pay $1,000,000 in cash by July 31, 2020. As a result of the commitment to fulfill a portion of our obligation by providing maintenance services at no cost, the royalty liability was significantly reduced, with a corresponding increase to deferred revenues. The fair value of the royalty liability as of July 31, 2018 was determined based on the amount payable in cash. As of July 31, 2018, and January 31, 2018, the present value of this royalty liability was $874,000 and $2,469,000, respectively. Acquisition of Opportune IT Healthcare Solutions, Inc. On September 8, 2016, we completed the acquisition of substantially all of the assets of Opportune IT Healthcare Solutions, Inc. (“Opportune IT”), a provider of coding compliance, recovery audit contractor consulting, and ICD‑10 readiness and training to hospitals, physicians and medical groups. As consideration under the asset purchase agreement, we made a cash payment for the total purchase price of $1,400,000. The Company also assumed certain current operating liabilities of Opportune IT.

Leases

6 Months Ended

Jul. 31, 2018

Leases

LEASES

NOTE 4 — LEASES

We rent office space and equipment under non-cancelable operating leases that expire at various times through fiscal year 2022. Future minimum lease payments under non-cancelable operating leases for the next five fiscal years are as follows:


	Facilities		Equipment		Fiscal Year Totals
2018 (six months remaining)	$	524,000	$	4,000	$	528,000
2019		967,000		7,000		974,000
2020		504,000		7,000		511,000
2021		519,000		7,000		526,000
2022		445,000		11,000		456,000
Total	$	2,959,000	$	36,000	$	2,995,000

In the second quarter of fiscal 2018, we closed our New York office and subleased the office space for the remaining period of the original lease term. As a result of vacating and subleasing the office, we recorded an $806,000 loss on exit of the operating lease in the second quarter of fiscal 2018. As of July 31, 2018, the total minimum rentals to be received under this non-cancelable sublease was $360,000.

Rent and leasing expense for facilities and equipment was $486,000 and $312,000 for the three months ended July 31, 2018 and 2017, respectively, and $803,000 and $625,000 for the six months ended July 31, 2018 and 2017.

In fiscal 2018, we entered into a new capital lease to finance our equipment purchases. Total cost and accumulated depreciation of fixed assets acquired under our outstanding capital lease were $67,000 and $17,000 as of July 31, 2018, respectively. As of January 31, 2018, we had no capital lease obligations outstanding. The current and non-current portions of our capital lease obligation are included in other current and other non-current liabilities, respectively. The amortization expense of the leased equipment was included in depreciation expense.

Debt

6 Months Ended

Jul. 31, 2018

Debt

DEBT

NOTE 5 — DEBT

Term Loan and Line of Credit

On November 21, 2014, we entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, N.A., as administrative agent, and other lender parties thereto. Pursuant to the Credit Agreement, the lenders agreed to provide a $10,000,000 senior term loan and a $5,000,000 revolving line of credit to our primary operating subsidiary. Amounts outstanding under the Credit Agreement bear interest at either LIBOR or the base rate, as elected by the Company, plus an applicable margin. Subject to the Company’s leverage ratio, under the terms of the original Credit Agreement, the applicable LIBOR rate margin varied from 4.25% to 5.25%, and the applicable base rate margin varied from 3.25% to 4.25%. Pursuant to the terms of the amendment to the Credit Agreement entered into as of April 15, 2015, the applicable LIBOR rate margin was amended to vary from 4.25% to 6.25%, and the applicable base rate margin was amended to vary from 3.25% to 5.25%. The term loan and line of credit mature on November 21, 2019 and provide support for working capital, capital expenditures and other general corporate purposes, including permitted acquisitions. The outstanding senior term loan is secured by substantially all of our assets. The senior term loan principal balance is payable in quarterly installments, which started in March 2015 and will continue through the maturity date, with the full remaining unpaid principal balance due at maturity. In November 2014, the Company repaid indebtedness under its prior credit facility using approximately $7,400,000 of the proceeds provided by the term loan. The prior credit facility with Fifth Third Bank was terminated concurrent with the entry into the Credit Agreement. Financing costs of $355,000 associated with the new credit facility are being amortized over its term on a straight-line basis, which is not materially different from the effective interest method.

The Credit Agreement includes customary financial covenants, including the requirements that the Company maintain minimum liquidity and achieve certain minimum EBITDA levels (as defined in the Credit Agreement). In addition, the Credit Agreement prohibits the Company from paying dividends on the common and preferred stock. Pursuant to the terms of the third amendment to the Credit Agreement entered into as of June 19, 2017, the Company is required to maintain minimum liquidity of at least (i) $5,000,000 through January 31, 2018, (ii) $4,000,000 from February 1, 2018 through and including January 31, 2019, and (iii) $3,000,000 from February 1, 2019 through and including the maturity date of the credit facility.

The following table shows our minimum trailing four quarter period EBITDA covenant thresholds, as modified by the third amendment to the Credit Agreement:


For the four-quarter period ending	Minimum EBITDA
July 31, 2017	$	(1,250,000)
October 31, 2017		(1,000,000)
January 31, 2018		(700,000)
April 30, 2018		(35,869)
July 31, 2018		414,953
October 31, 2018		1,080,126
January 31, 2019		1,634,130
April 30, 2019		1,842,610
July 31, 2019		2,657,362
October 31, 2019 and each fiscal quarter thereafter		3,613,810

The Company was in compliance with the applicable financial loan covenants at July 31, 2018.

As of July 31, 2018, the Company had no outstanding borrowings under the revolving line of credit, and had accrued $32,000 in unused line fees. Based upon the borrowing base formula set forth in the Credit Agreement, as of July 31, 2018, the Company had access to the full amount of the $5,000,000 revolving line of credit.

Outstanding principal balances on debt consisted of the following at:


	July 31, 2018		January 31, 2018
Senior term loan	$	4,328,000	$	4,626,000
Capital lease (1)		67,000		—
Total		4,395,000		4,626,000
Deferred financing cost		(93,000)		(128,000)
Total		4,302,000		4,498,000
Less: Current portion		(634,000)		(597,000)
Non-current portion of debt	$	3,668,000	$	3,901,000

(1)

The current and non-current portions of our capital lease obligation are included in other current and other non-current liabilities, respectively.

Future principal repayments of debt consisted of the following at July 31, 2018:


Fiscal year	Senior Term Loan (1)
2018	$	298,000
2019		4,030,000
Total repayments	$	4,328,000

(1)

Term loan balance on the condensed consolidated balance sheet is reported net of deferred financing costs of $93,000.

Convertible Preferred Stock	6 Months Ended
Convertible Preferred Stock	Jul. 31, 2018
Convertible Preferred Stock
CONVERTIBLE PREFERRED STOCK	NOTE 6 — CONVERTIBLE PREFERRED STOCK Series A Convertible Preferred Stock At July 31, 2018, we had 2,895,464 shares of Series A Convertible Redeemable Preferred Stock (the “Preferred Stock”) outstanding. Each share of the Preferred Stock is convertible into one share of the Company’s common stock. The Preferred Stock does not pay a dividend; however, the holders are entitled to receive dividends equal (on an as-if-converted-to-common-stock basis) to and in the same form as dividends (other than dividends in the form of common stock) actually paid on shares of the common stock. The Preferred Stock has voting rights on a modified as-if-converted-to-common-stock-basis. The Preferred Stock has a non-participating liquidation right equal to the original issue price plus accrued unpaid dividends, which are senior to the Company’s common stock. The Preferred Stock can be converted to common shares at any time by the holders, or at the option of the Company if the arithmetic average of the daily volume weighted average price of the common stock for the 10 day period prior to the measurement date is greater than $8.00 per share, and the average daily trading volume for the 60 day period immediately prior to the measurement date exceeds 100,000 shares. The conversion price is $3.00 per share, subject to certain adjustments. At any time following August 31, 2016, subject to the terms of the Subordination and Intercreditor Agreement among the preferred stockholders, the Company and Wells Fargo, which prohibits the redemption of the Preferred Stock without the consent of Wells Fargo, each share of Preferred Stock is redeemable at the option of the holder for an amount equal to the initial issuance price of $3.00 (adjusted to reflect stock splits, stock dividends or similar events) plus any accrued and unpaid dividends thereon. The Preferred Stock is classified as temporary equity as the securities are redeemable solely at the option of the holder.

Income Taxes	6 Months Ended
Income Taxes	Jul. 31, 2018
Income Taxes
INCOME TAXES	NOTE 7 — INCOME TAXES Income tax expense consists of federal, state and local tax provisions. For the six months ended July 31, 2018 and 2017, we recorded federal tax expense of zero. For the six months ended July 31, 2018 and 2017, we recorded state and local tax expense of $3,000 and $5,000, respectively.

Subsequent Events	6 Months Ended
Subsequent Events	Jul. 31, 2018
Subsequent Events
SUBSEQUENT EVENTS	NOTE 8 — SUBSEQUENT EVENTS We have evaluated subsequent events occurring after July 31, 2018, and based on our evaluation we did not identify any events that would have required recognition or disclosure in these condensed consolidated financial statements.

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jul. 31, 2018

Summary of Significant Accounting Policies

Use of Estimates

Fair Value of Financial Instruments

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

Revenue Recognition

Contract Receivables and Deferred Revenues

The Company receives payments from customers based upon contractual billing schedules. Contract receivables include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Deferred revenues include payments received in advance of performance under the contract. Our contract receivables and deferred revenue are reported on an individual contract basis at the end of each reporting period. Contract receivables are classified as current or noncurrent based on the timing of when we expect to bill the customer. Deferred revenue is classified as current or noncurrent based on the timing of when we expect to recognize revenue. In the six-month period ended July 31, 2018, we recognized $3,924,000 in revenue from deferred revenues outstanding as of January 31, 2018.

Revenue Recognition

We commence revenue recognition (Step 5 below) in accordance with that core principle after applying the following steps:

Step 1: Identify the contract(s) with a customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract in the contract

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

Contract Combination

Systems Sales

Maintenance and Support Services

Our support and maintenance obligations include multiple discrete performance obligations, with the two largest being unspecified product upgrades or enhancements, and technical support, which can be offered at various points during a contract period. We believe that the multiple discrete performance obligations within our overall support and maintenance obligations can be viewed as a single performance obligation since both the unspecified upgrades and technical support are activities to fulfill the maintenance performance obligation and are rendered concurrently. Annual maintenance and support agreements entitle clients to technology support, version upgrades, bug fixes and service packs. We recognize maintenance and support revenue over time.

Software-Based Solution Professional Services

Software as a Service

We defer the direct costs, which includes salaries and benefits, for professional services related to SaaS contracts. These deferred costs will be amortized over the identical term as the associated revenues. As of July 31, 2018, and January 31, 2018, we had deferred costs of $000 and $471,000, respectively, net of accumulated amortization of $000 and $312,000, respectively. Amortization expense of these costs was $000 and $43,000 for the three months ended July 31, 2018 and 2017, respectively and $000 and $126,000 for the six months ended July 31, 2018 and 2017, respectively.

Audit Services

Audit services are a separate performance obligation. We recognize revenue over time as the services are performed.

Deferred commissions costs (contract acquisition costs)

Transaction price allocated to the remaining performance obligations

Deferred commissions costs (contract acquisition costs)

Severance

Equity Awards

Income Taxes

Net Earnings (Loss) Per Common Share

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jul. 31, 2018

Summary of Significant Accounting Policies

Fair Value of Liabilities on a Recurring Basis

The table below provides information on our liabilities that are measured at fair value on a recurring basis:


			Quoted Prices in		Significant Other		Significant
	Total Fair		Active Markets		Observable Inputs		Unobservable Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
At July 31, 2018
Royalty liability (1) (3)	$	874,000	$	—	$	—	$	874,000

At January 31, 2018
Royalty liability (1) (2)	$	2,469,000	$	—	$	—	$	2,469,000

(1)

(2)

Schedule of Adoption of New Accounting Standard

The cumulative effect of changes related to the adoption of ASC 606 are reflected in the opening balance of accumulated deficit as shown below:


	As Reported January 31, 2018		Adjustments due to ASC 606		As Adjusted February 1, 2018
ASSETS
Contract receivables, current	$	224,000	$	283,000	$	507,000
Contract receivables, noncurrent		—		468,000		468,000

LIABILITIES
Deferred revenues, current		9,482,000		(689,000)		8,793,000

STOCKHOLDERS' EQUITY
Accumulated deficit	$	(72,125,000)	$	1,440,000	$	(70,685,000)

The adoption of the new standard has the following impact to the Company’s condensed consolidated statements of operations:


	Six Months Ended July 31, 2018
	As reported under ASC 606		Balances without adoption of ASC 606		Adjustments due to ASC 606
Revenues
Systems sales	$	1,518,000	$	2,008,000	$	(490,000)
Maintenance and support		6,525,000		6,529,000		(4,000)


	As of July 31, 2018
	As reported under ASC 606		Balances without adoption of Topic 606		Adjustments due to ASC 606
Assets
Contract receivables, current	$	826,000	$	474,000	$	352,000
Contract receivables, noncurrent		683,000		190,000		493,000

Liabilities
Deferred revenues, current		8,273,000		8,414,000		(141,000)

Shareholders' Equity
Accumulated deficit	$	(72,776,000)	$	(73,762,000)	$	986,000

Schedule of Disaggregated Revenue

The following table provides information about disaggregated revenue by type and nature of revenue stream:


	Six Months Ended July 31, 2018
	Recurring Revenue		Non-recurring Revenue		Total
Systems sales	$	166,000	$	1,352,000	$	1,518,000
Professional services		—		509,000		509,000
Audit services		—		608,000		608,000
Maintenance and support		6,525,000		—		6,525,000
Software as a service		2,372,000		—		2,372,000
Total revenue:	$	9,063,000	$	2,469,000	$	11,532,000

Schedule of Earnings Per Share, Basic and Diluted

The following is the calculation of the basic and diluted net loss per share of common stock:


	Three Months Ended
	July 31, 2018		July 31, 2017
Net loss	$	(1,522,208)	$	(1,098,065)
Weighted average shares outstanding - Basic		19,971,090		19,834,859
Stock options, restricted stock, Series A Convertible Preferred Stock and warrants		—		—
Weighted average shares outstanding - Diluted		19,971,090		19,834,859
Basic net loss per share of common stock	$	(0.08)	$	(0.06)
Diluted net loss per share of common stock	$	(0.08)	$	(0.06)


	Six Months Ended
	July 31, 2018		July 31, 2017
Net loss	$	(2,090,907)	$	(3,140,573)
Weighted average shares outstanding - Basic		19,978,757		19,765,125
Stock options, restricted stock, Series A Convertible Preferred Stock and warrants		—		—
Weighted average shares outstanding - Diluted		19,978,757		19,765,125
Basic net loss per share of common stock	$	(0.10)	$	(0.16)
Diluted net loss per share of common stock	$	(0.10)	$	(0.16)

Leases (Tables)

6 Months Ended

Jul. 31, 2018

Leases

Schedule of Future Minimum Lease Payment

Future minimum lease payments under non-cancelable operating leases for the next five fiscal years are as follows:


	Facilities		Equipment		Fiscal Year Totals
2018 (six months remaining)	$	524,000	$	4,000	$	528,000
2019		967,000		7,000		974,000
2020		504,000		7,000		511,000
2021		519,000		7,000		526,000
2022		445,000		11,000		456,000
Total	$	2,959,000	$	36,000	$	2,995,000

Debt (Tables)

6 Months Ended

Jul. 31, 2018

Debt

Minimum Trailing Four Quarter Period EBITDA Covenant Thresholds

The following table shows our minimum trailing four quarter period EBITDA covenant thresholds, as modified by the third amendment to the Credit Agreement:


For the four-quarter period ending	Minimum EBITDA
July 31, 2017	$	(1,250,000)
October 31, 2017		(1,000,000)
January 31, 2018		(700,000)
April 30, 2018		(35,869)
July 31, 2018		414,953
October 31, 2018		1,080,126
January 31, 2019		1,634,130
April 30, 2019		1,842,610
July 31, 2019		2,657,362
October 31, 2019 and each fiscal quarter thereafter		3,613,810

Summary of Term Loan and Line of Credit

Outstanding principal balances on debt consisted of the following at:


	July 31, 2018		January 31, 2018
Senior term loan	$	4,328,000	$	4,626,000
Capital lease (1)		67,000		—
Total		4,395,000		4,626,000
Deferred financing cost		(93,000)		(128,000)
Total		4,302,000		4,498,000
Less: Current portion		(634,000)		(597,000)
Non-current portion of debt	$	3,668,000	$	3,901,000

(1)

The current and non-current portions of our capital lease obligation are included in other current and other non-current liabilities, respectively.

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

Summary of Significant Accounting Policies - Fair Value of Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2018	Jan. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Royalty liability	$ 874	$ 2,469
Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Royalty liability	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Royalty liability	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Royalty liability	$ 874	$ 2,469

Summary of Significant Accounting Policies - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017	Feb. 01, 2018	Jan. 31, 2018
Class of Stock [Line Items]
Deferred professional costs	$ 335,000		$ 335,000			$ 471,000
Accumulated amortization of deferred costs	443,000		443,000			312,000
Amortization of deferred costs	91,000	$ 43,000	193,000	$ 126,000
Revenue recognized			6,791,000
Severance expenses	4,000	3,000	17,000	58,000
Accrued severances	6,000		6,000			0
Share-based compensation expense	144,000	$ 288,000	366,906	555,229
Cost of shares for tax withholding			57,699	$ 37,002
Reserves for uncertain tax positions and corresponding interest and penalties	$ 314,000		$ 314,000			$ 286,000
ASU 2014-09 \| Retained Earnings
Class of Stock [Line Items]
Cumulative effect of new accounting principle in period of adoption					$ 1,400,000
Restricted Stock
Class of Stock [Line Items]
Antidilutive securities (in shares)	649,087	831,587	649,087	831,587
Stock Option
Class of Stock [Line Items]
Antidilutive securities (in shares)	1,763,795	2,239,047	1,763,795	2,239,047
Warrant
Class of Stock [Line Items]
Antidilutive securities (in shares)		1,400,000		1,400,000
Series A Preferred Stock
Class of Stock [Line Items]
Convertible redeemable preferred stock, shares outstanding (in shares)	2,895,464		2,895,464			2,949,995
Number of common shares for each convertible preferred share (in shares)	1		1
Restricted Stock
Class of Stock [Line Items]
Shares surrendered for tax withholding (in shares)			33,392
Cost of shares for tax withholding			$ 58,000
Minimum \| Restricted Stock
Class of Stock [Line Items]
Service period (in years)			1 year
Maximum \| Restricted Stock \| Restricted Stock
Class of Stock [Line Items]
Service period (in years)			4 years

Summary of Significant Accounting Policies - Impact on Statements of Operations From Adoption of New Accounting Standard (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Systems sales	$ 385,875	$ 328,692	$ 1,517,549	$ 707,415
Maintenance and support	$ 3,216,251	$ 3,278,562	6,525,355	$ 6,633,334
Balances without adoption of ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Systems sales			2,008,000
Maintenance and support			6,529,000
ASU 2014-09 \| Adjustments due to ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Systems sales			(490,000)
Maintenance and support			$ (4,000)

Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
Disaggregation of Revenue [Line Items]
Systems sales	$ 385,875	$ 328,692	$ 1,517,549	$ 707,415
Professional services	271,121	571,812	509,435	991,847
Audit services	247,843	294,441	607,556	639,460
Maintenance and support	3,216,251	3,278,562	6,525,355	6,633,334
Software as a service	1,147,642	1,442,652	2,372,010	2,867,784
Total revenues	$ 5,268,732	$ 5,916,159	11,531,905	$ 11,839,840
Content Management
Disaggregation of Revenue [Line Items]
Systems sales			166,000
Professional services			0
Audit services			0
Maintenance and support			6,525,000
Software as a service			2,372,000
Total revenues			9,063,000
Financial Management
Disaggregation of Revenue [Line Items]
Systems sales			1,352,000
Professional services			509,000
Audit services			608,000
Maintenance and support			0
Software as a service			0
Total revenues			2,469,000
Coding & CDI
Disaggregation of Revenue [Line Items]
Systems sales			1,518,000
Professional services			509,000
Audit services			608,000
Maintenance and support			6,525,000
Software as a service			2,372,000
Total revenues			$ 11,532,000

Summary of Significant Accounting Policies - Impact on the Balance Sheets From Adoption of New Accounting Standard (Details) - USD ($)	Jul. 31, 2018	Feb. 01, 2018	Jan. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract receivables, current	$ 826,277	$ 507,000	$ 223,791
Contract receivables, noncurrent	683,031	468,000	0
Deferred revenues	8,273,251	8,793,000	9,481,807
Accumulated deficit	(72,776,024)	(70,685,000)	(72,125,065)
Balances without adoption of ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract receivables, current	474,000		224,000
Contract receivables, noncurrent	190,000		0
Deferred revenues	8,414,000		9,482,000
Accumulated deficit	(73,762,000)		$ (72,125,000)
Adjustments due to ASC 606 \| ASU 2014-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract receivables, current	352,000	283,000
Contract receivables, noncurrent	493,000	468,000
Deferred revenues	(141,000)	(689,000)
Accumulated deficit	$ 986,000	$ 1,440,000

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References + Details

Summary of Significant Accounting Policies - Revenue Performance Obligations (Details) $ in Millions	6 Months Ended
	Jul. 31, 2018 USD ($)
Summary of Significant Accounting Policies
Remaining performance obligations	$ 23
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Percentage of remaining performance obligation to be recognized over the next 12 months	62.00%
Period in which remaining performance obligation is expected to be satisfied	1 year

Summary of Significant Accounting Policies - Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
Summary of Significant Accounting Policies
Net loss	$ (1,522,208)	$ (1,098,065)	$ (2,090,907)	$ (3,140,573)
Weighted average number of common shares - basic and diluted (in shares)	19,971,090	19,834,859	19,978,757	19,765,125
Stock options, restricted stock, Series A Convertible Preferred Stock and warrants (in shares)	0	0
Weighted average shares outstanding - Diluted (in shares)	19,971,090	19,834,859	19,978,757	19,765,125
Basic net loss per common stock (in dollars per share)	$ (0.08)	$ (0.06)	$ (0.10)	$ (0.16)
Diluted net loss per common stock (in dollars per share)	$ (0.08)	$ (0.06)	$ (0.10)	$ (0.16)

Acquisitions and Divestitures - Narrative (Details) - USD ($)	Jul. 01, 2018	Sep. 08, 2016	Oct. 25, 2013	Jul. 31, 2018	Jan. 31, 2018
Business Acquisition [Line Items]
Royalty liability				$ 874,437	$ 2,469,193
Royalty liability				$ 874,000	$ 2,469,000
Montefiore Medical Center
Business Acquisition [Line Items]
Proprietary lease term (in years)			15 years
Royalty fee			$ 3,000,000
Additional payment	$ 1,000,000		$ 3,000,000
Maintenance term	24 months
Periodic royalty payment, term (in years)			6 years 6 months
Opportune IT Healthcare Solutions, Inc.
Business Acquisition [Line Items]
Total purchase price		$ 1,400,000

Leases (Details) - USD ($)	3 Months Ended		6 Months Ended
Leases (Details) - USD ($)	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017	Jan. 31, 2018
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2018 (six months remaining)	$ 528,000		$ 528,000
2019	974,000		974,000
2020	511,000		511,000
2021	526,000		526,000
2022	456,000		456,000
Total	2,995,000		2,995,000
Loss on exit of operating lease	(806,163)		(806,163)
Total sublease rentals to be received	360,000		360,000
Rent expense	486,000	$ 312,000	803,000	$ 625,000
Capital lease obligations	67,000		67,000		$ 0
Facilities
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2018 (six months remaining)	524,000		524,000
2019	967,000		967,000
2020	504,000		504,000
2021	519,000		519,000
2022	445,000		445,000
Total	2,959,000		2,959,000
Equipment
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2018 (six months remaining)	4,000		4,000
2019	7,000		7,000
2020	7,000		7,000
2021	7,000		7,000
2022	11,000		11,000
Total	36,000		36,000
Capital lease, cost	67,000		67,000
Capital lease, accumulated depreciation	$ 17,000		$ 17,000

Debt - Narrative (Details) - USD ($)			1 Months Ended	6 Months Ended
Debt - Narrative (Details) - USD ($)	Apr. 15, 2015	Nov. 21, 2014	Nov. 30, 2014	Jul. 31, 2018
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit amount outstanding				$ 0
Commitment fee in connection with the term loan				32,000
Credit Agreement
Debt Instrument [Line Items]
Repayments of debt			$ 7,400,000
Amortization of financing costs	$ 355,000
Credit Agreement \| Senior Notes
Debt Instrument [Line Items]
Revolving line of credit		$ 10,000,000
Credit Agreement \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving line of credit		$ 5,000,000
LIBOR \| Credit Agreement \| Minimum
Debt Instrument [Line Items]
Basis spread on interest rate (as a percent)	4.25%	4.25%
LIBOR \| Credit Agreement \| Maximum
Debt Instrument [Line Items]
Basis spread on interest rate (as a percent)	6.25%	5.25%
Base Rate \| Credit Agreement \| Minimum
Debt Instrument [Line Items]
Basis spread on interest rate (as a percent)	3.25%	3.25%
Base Rate \| Credit Agreement \| Maximum
Debt Instrument [Line Items]
Basis spread on interest rate (as a percent)	5.25%	4.25%
Current to January 31, 2018
Debt Instrument [Line Items]
Minimum liquidity				5,000,000
February 1, 2018 through January 31, 2019
Debt Instrument [Line Items]
Minimum liquidity				4,000,000
February 1, 2019 through maturity
Debt Instrument [Line Items]
Minimum liquidity				$ 3,000,000

Debt - EBITDA Covenant Thresholds (Details) - Credit Agreement	6 Months Ended
	Jul. 31, 2018 USD ($)
July 31, 2017
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	$ (1,250,000)
October 31, 2017
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	(1,000,000)
January 31, 2018
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	(700,000)
April 30, 2018
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	(35,869)
July 31, 2018
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	414,953
October 31, 2018
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	1,080,126
January 31, 2019
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	1,634,130
April 30, 2019
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	1,842,610
July 31, 2019
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	2,657,362
October 31, 2019 and each fiscal quarter thereafter
Debt Instrument [Line Items]
Debt covenant, minimum EBITDA	$ 3,613,810

Debt - Summary of Term Loan and Line of Credit (Details) - USD ($)	Jul. 31, 2018	Jan. 31, 2018
Debt Instrument [Line Items]
Capital lease	$ 67,000	$ 0
Total	4,395,000	4,626,000
Less: Current portion	(596,984)	(596,984)
Senior Notes
Debt Instrument [Line Items]
Long-term debt	4,328,000	4,626,000
Deferred financing cost	(93,000)	(128,000)
Total	4,302,000	4,498,000
Less: Current portion	(634,000)	(597,000)
Non-current portion of debt	$ 3,668,000	$ 3,901,000

Debt - Schedule of Future Principal Repayments of Long-Term Debt (Details) - Senior Notes - USD ($) $ in Thousands	Jul. 31, 2018	Jan. 31, 2018
Senior Term Loan
2018	$ 298
2019	4,030
Total	4,328	$ 4,626
Deferred finance costs	$ 93	$ 128

Convertible Preferred Stock (Details) - Series A Preferred Stock	6 Months Ended
	Jul. 31, 2018 $ / shares shares
Class of Stock [Line Items]
Preferred stock, shares issued (in shares) \| shares	2,895,464
Number of common shares for each convertible preferred share (in shares) \| shares	1
Maximum period of conversion (in days)	10 days
Minimum share price (in dollars per share) (greater than) \| $ / shares	$ 8.00
Average daily trading volume period prior to measurement date (in days)	60 days
Average daily trading volume minimum shares (in shares) \| shares	100,000
Price per share at time of conversion (in dollars per share) \| $ / shares	$ 3.00
Shares issued, price per share (in dollars per share) \| $ / shares	$ 3.00

Income Taxes (Details) - USD ($)	6 Months Ended
Income Taxes (Details) - USD ($)	Jul. 31, 2018	Jul. 31, 2017
Income Taxes
Federal tax expense	$ 0	$ 0
State and local tax provisions	$ 3,000	$ 5,000